- Home
- IIM vs NPCE Comparison
IIM vs NPCE Comparison
Compare IIM & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
HOLD
Current Price
$15.75
Company Overview
Basic Information| Metric | IIM | NPCE |
|---|---|---|
| Founded | 1993 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 574.2M | 514.3M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | IIM | NPCE |
|---|---|---|
| Price | $12.35 | $15.75 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $18.14 |
| AVG Volume (30 Days) | 122.2K | ★ 243.9K |
| Earning Date | 01-01-0001 | 03-03-2026 |
| Dividend Yield | ★ 4.63% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | N/A | ★ $94,864,000.00 |
| Revenue This Year | N/A | $25.30 |
| Revenue Next Year | N/A | $0.42 |
| P/E Ratio | $591.50 | ★ N/A |
| Revenue Growth | N/A | ★ 24.08 |
| 52 Week Low | $9.94 | $7.56 |
| 52 Week High | $12.32 | $18.98 |
Technical Indicators
Market Signals| Indicator | IIM | NPCE |
|---|---|---|
| Relative Strength Index (RSI) | 47.21 | 44.45 |
| Support Level | $12.52 | $16.20 |
| Resistance Level | $12.63 | $17.44 |
| Average True Range (ATR) | 0.09 | 0.85 |
| MACD | -0.02 | -0.16 |
| Stochastic Oscillator | 30.44 | 2.03 |
Price Performance
Historical Comparison IIM
NPCE
About IIM Invesco Value Municipal Income Trust
Invesco Value Municipal Income Trust is a diversified, closed-end management investment company. Its investment objective is to provide common shareholders with current income that is exempt from federal income tax.
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.